Scavenger receptor class B type I is more conducive for genotype 1b hepatitis C virus internalization than low-density lipoprotein receptor.

IF 1.1 4区 医学 Q4 VIROLOGY Acta virologica Pub Date : 2021-01-01 DOI:10.4149/av_2021_307
Xiangyi Cao, Qiong Kang, Jiang Deng, Jun Xiao, Yanyu Zhang, Ping Ma, Xiaoang Yang, Liping Lv
{"title":"Scavenger receptor class B type I is more conducive for genotype 1b hepatitis C virus internalization than low-density lipoprotein receptor.","authors":"Xiangyi Cao,&nbsp;Qiong Kang,&nbsp;Jiang Deng,&nbsp;Jun Xiao,&nbsp;Yanyu Zhang,&nbsp;Ping Ma,&nbsp;Xiaoang Yang,&nbsp;Liping Lv","doi":"10.4149/av_2021_307","DOIUrl":null,"url":null,"abstract":"<p><p>The current limited understanding of HCV entry mechanisms hinders the development of specific antiviral drug screening techniques and vaccine assessment. HCV subtypes and cellular surface proteins both can affect virus tropism. Human factors such as low-density lipoprotein receptor (hLDLR), CD81 (hCD81), scavenger receptor class B type I (hSR-BI), claudin 1 (hCLDN1), and occludin (hOCLN) assist HCV entry into hepatocytes. Here, we studied the importance of five human proteins in the process of cell culture-derived (HCVcc) and serum-derived (HCV-sd) HCV entry using constructed humanized mouse hepatocytes and mouse models. We determined that unlike hLDLR, hSR-BI was an indispensable factor for 1b genotype HCV adsorption. Furthermore, this attachment can be completely prevented by treatment with a monoclonal antibody targeting hSR-BI. Our data support the idea that SR-BI is an essential factor in HCV infection, particularly during the initial HCV particle-binding step. This novel finding will facilitate the development of antiviral drugs and vaccines. Keywords: hepatitis C virus; virus internalization; model construction; hSR-BI.</p>","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":"65 3","pages":"279-287"},"PeriodicalIF":1.1000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta virologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4149/av_2021_307","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The current limited understanding of HCV entry mechanisms hinders the development of specific antiviral drug screening techniques and vaccine assessment. HCV subtypes and cellular surface proteins both can affect virus tropism. Human factors such as low-density lipoprotein receptor (hLDLR), CD81 (hCD81), scavenger receptor class B type I (hSR-BI), claudin 1 (hCLDN1), and occludin (hOCLN) assist HCV entry into hepatocytes. Here, we studied the importance of five human proteins in the process of cell culture-derived (HCVcc) and serum-derived (HCV-sd) HCV entry using constructed humanized mouse hepatocytes and mouse models. We determined that unlike hLDLR, hSR-BI was an indispensable factor for 1b genotype HCV adsorption. Furthermore, this attachment can be completely prevented by treatment with a monoclonal antibody targeting hSR-BI. Our data support the idea that SR-BI is an essential factor in HCV infection, particularly during the initial HCV particle-binding step. This novel finding will facilitate the development of antiviral drugs and vaccines. Keywords: hepatitis C virus; virus internalization; model construction; hSR-BI.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乙型ⅰ型清道夫受体比低密度脂蛋白受体更有利于基因1b型丙型肝炎病毒的内化。
目前对HCV进入机制的有限了解阻碍了特定抗病毒药物筛选技术和疫苗评估的发展。HCV亚型和细胞表面蛋白都能影响病毒的趋向性。人为因素如低密度脂蛋白受体(hLDLR)、CD81 (hCD81)、清道夫受体B类I型(hSR-BI)、claudin 1 (hCLDN1)和occludin (hOCLN)协助HCV进入肝细胞。在这里,我们利用构建的人源化小鼠肝细胞和小鼠模型研究了五种人类蛋白在细胞培养源性(HCVcc)和血清源性(HCV-sd) HCV进入过程中的重要性。我们确定,与hLDLR不同,hSR-BI是1b基因型HCV吸附的不可或缺的因素。此外,这种附着可以通过靶向hSR-BI的单克隆抗体完全阻止。我们的数据支持SR-BI是HCV感染的重要因素,特别是在HCV颗粒结合的初始阶段。这一新发现将促进抗病毒药物和疫苗的开发。关键词:丙型肝炎病毒;病毒内化;模型构建;hSR-BI。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta virologica
Acta virologica 医学-病毒学
CiteScore
3.10
自引率
11.80%
发文量
43
审稿时长
>12 weeks
期刊介绍: Acta virologica is an international journal of predominantly molecular and cellular virology. Acta virologica aims to publish papers reporting original results of fundamental and applied research mainly on human, animal and plant viruses at cellular and molecular level. As a matter of tradition, also rickettsiae are included. Areas of interest are virus structure and morphology, molecular biology of virus-cell interactions, molecular genetics of viruses, pathogenesis of viral diseases, viral immunology, vaccines, antiviral drugs and viral diagnostics.
期刊最新文献
The interaction of influenza A virus RNA polymerase PA subunit with the human β-actin protein Construction of recombinant adenovirus-5 vector to prevent replication-competent adenovirus occurrence Virtual screening and molecular dynamics simulation to identify potential SARS-CoV-2 3CLpro inhibitors from a natural product compounds library The TRK-fused gene negatively regulates interferon signaling by inhibiting TBK1 phosphorylation during PPMV-1 infection Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1